Tempest Therapeutics (TPST) FCF Margin Growth (3y) (2018)
Tempest Therapeutics (TPST) FCF Margin Growth (3y) (2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn | -5,426.00 |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn | 9,545.00 |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 4,612.00 |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn | 1,850.00 |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | 14,060.00 |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | -3,088.00 |
| 10 | Tempest Therapeutics | 4.34 Mn | 3.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 965,176.00 |
| Jun 30, 2018 | 3.69 Mn |
| Mar 31, 2018 | 9.11 Mn |